SRRK
Scholar Rock Holding Corp
NASDAQ · Healthcare · Biotechnology · US
$46.65
−4.83%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.86
- Revenue estimate
- $732.5K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.84
- EPS estimate
- -$0.84
- Revenue actual
- —
- Revenue estimate
- $3.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- -2.2%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $71
- PT range
- $58 – $84
- Analysts
- 11
10 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.84 | -$0.84 | Beat 0.06% | — |
| May 7, 2026 | -$0.82 | -$0.83 | Miss -1.22% | — |
| Mar 3, 2026 | -$0.88 | -$0.88 | Beat 0.29% | — |
| Nov 14, 2025 | -$0.84 | -$0.90 | Miss -7.76% | — |
| Aug 6, 2025 | -$0.66 | -$0.98 | Miss -48.48% | — |
| May 14, 2025 | -$0.63 | -$0.67 | Miss -6.35% | — |
| Feb 27, 2025 | -$0.60 | -$0.60 | In line | — |
| Mar 19, 2024 | -$0.49 | -$0.50 | Miss -2.04% | $11.7M |
| Mar 7, 2023 | -$0.58 | -$0.46 | Beat 20.69% | $33.2M |
| Nov 14, 2022 | -$0.68 | -$0.55 | Beat 19.12% | — |
| May 16, 2022 | -$0.79 | -$0.21 | Beat 73.42% | $33.2M |
| Mar 7, 2022 | -$1.04 | -$0.97 | Beat 6.73% | $4.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026